- STAT+: Prometheus raises $12 billion in capital for artificial engineersNonprofit Blood Cancer United acquires cancer drug, Lilly and Nvidia invest in Abridge, and more biotech newsSTAT · 1mo ago↗ source
- Rapport ‘fully prepared’ to launch seizure drug solo, CEO says<p>In a wide-ranging interview, Abe Ceesay detailed how Rapport built an investor syndicate and why the company is confident it can join the ranks of successful, commercial-stage brain drugmakers.</p>BioPharma Dive · 1mo ago↗ source
- STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and moreThe nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta